MedTrace Logo

Clinical Efficacy of Amoxicillin Given Twice or Three Times a Day Among Children With Non-severe Pneumonia

NCT01200706 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 820

Last updated 2011-07-20

No results posted yet for this study

Summary

The purpose of the study is to compare the clinical efficacy of amoxicillin given twice or three times a day to children with non-severe community-acquired pneumonia.

Conditions

  • Community-acquired Pneumonia

Interventions

DRUG

Amoxicillin

amoxicillin 50mg/kg/day given in two different administration schemes

Sponsors & Collaborators

  • Federal University of Bahia

    lead OTHER

Principal Investigators

  • Cristiana M Nascimento-Carvalho, MD, PhD · Federal University of Bahia School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
2 Months
Max Age
59 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-11-30
Primary Completion
2011-05-31
Completion
2011-05-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01200706 on ClinicalTrials.gov